Casdin Capital, LLC - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 66 filers reported holding HOMOLOGY MEDICINES INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q3 2019$14,842,000,000
+1.8%
820,000
+10.1%
1.54%
+12.5%
Q2 2019$14,579,650,000
+150112.8%
745,000
+112.9%
1.36%
+28.0%
Q1 2019$9,706,000
+24.0%
350,0000.0%1.07%
-20.4%
Q4 2018$7,826,000
-2.2%
350,0000.0%1.34%
+37.8%
Q3 2018$8,001,000
+241.0%
350,000
+204.3%
0.97%
+196.3%
Q2 2018$2,346,000
+109.1%
115,000
+91.7%
0.33%
+66.5%
Q1 2018$1,122,00060,0000.20%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q1 2019
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$16,511,0003.10%
Vida Ventures Advisors, LLC 770,845$2,806,0001.05%
Vivo Capital, LLC 853,143$3,105,0000.19%
AAF Wealth Management, LLC 47,501$173,0000.12%
OUP Management Co., LLC 64,000$233,0000.10%
GSA CAPITAL PARTNERS LLP 195,596$712,0000.09%
Temasek Holdings (Private) Ltd 5,650,996$20,570,0000.07%
Bellevue Group AG 1,737,122$6,323,0000.06%
XTX Topco Ltd 26,212$95,0000.05%
Virtus ETF Advisers LLC 37,588$137,0000.05%
View complete list of HOMOLOGY MEDICINES INC shareholders